Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will p...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Kim, Hae Won (Επιμελητής έκδοσης), Greenburg, A. Gerson (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02946nam a22005175i 4500
001 978-3-642-40717-8
003 DE-He213
005 20151103141120.0
007 cr nn 008mamaa
008 131218s2013 gw | s |||| 0|eng d
020 |a 9783642407178  |9 978-3-642-40717-8 
024 7 |a 10.1007/978-3-642-40717-8  |2 doi 
040 |d GrThAP 
050 4 |a R857.M3 
072 7 |a TGM  |2 bicssc 
072 7 |a TCB  |2 bicssc 
072 7 |a TEC021000  |2 bisacsh 
072 7 |a SCI009000  |2 bisacsh 
082 0 4 |a 620.11  |2 23 
245 1 0 |a Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics  |h [electronic resource] /  |c edited by Hae Won Kim, A. Gerson Greenburg. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2013. 
300 |a XXIII, 746 p. 130 illus., 77 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Brief historical account of HBOC development -- Physiology of respiration -- Oxygen transport to tissues -- Pathophysiology of acute anemia -- Global blood safety and need for safe blood supply -- Blood transfusion and its limitations -- Scientific basis and design of HBOCs -- HBOCs: a regulatory perspective -- Current HBOC products in development -- Clinical indications and clinical trials of HBOCs -- HBOCs and adverse events observed in clinical trials -- HBOC-mediated vasoactivity and hypertension -- HBOC and oxygen and nitrogen radical mediated toxicity -- HBOCs and clinical laboratory interference -- Animal models for HBOC studies -- New emerging Technologies for universal RBCs -- Future prospects. 
520 |a Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects. 
650 0 |a Materials science. 
650 0 |a Molecular biology. 
650 0 |a Medicinal chemistry. 
650 0 |a Hematology. 
650 0 |a Biomaterials. 
650 1 4 |a Materials Science. 
650 2 4 |a Biomaterials. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Medicinal Chemistry. 
650 2 4 |a Hematology. 
700 1 |a Kim, Hae Won.  |e editor. 
700 1 |a Greenburg, A. Gerson.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642407161 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-40717-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-CMS 
950 |a Chemistry and Materials Science (Springer-11644)